CRISPR Therapeutics AG
CRSP · Healthcare · · USDFahodi Score SELL Mid-term (Position)
49
/ 100
Technical
50
Trend & RS
40
Momentum
52
Fundamental
33
Macro
71
Liquidity
27
| Component | Score | Weight |
|---|---|---|
| Technical | 50.0 | 20% |
| Trend & RS | 39.7 | 30% |
| Momentum | 52.1 | 15% |
| Fundamental | 33.3 | 10% |
| Macro | 71.2 | 20% |
| Liquidity | 27.2 | 5% |
Trade Setup
| Entry | 54.39 |
| Stop Loss | 47.65 (12.4%) |
| Target 1 (1:1) | 61.13 (+12.4%) |
| Target 2 (2:1) | 67.87 (+24.8%) |
| ATR(14) | 3.37 (6.2%) |
| Risk per Share | 6.74 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 75.4 | +1.01 | |
| Momentum | 52.1 | +0.08 | |
| Quality | 40.0 | -0.40 | |
| Composite | 55.8 | ||
Quality Scores
Piotroski F-Score
3
/9 —
Weak
✗
✗
✗
✗
✓
✓
✗
✗
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Undervalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | N/A | 22.0 | Inline |
| P/B Ratio | 2.8 | 4.0 | Below |
Comparing against Healthcare median multiples.
Trading at a discount to sector peers — potential value opportunity.
Position Sizing — Kelly Criterion
4.8%
Recommended Size
31.54%
Full Kelly
15.77%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 49/100. Estimated win rate 55%, avg win 7.9%, avg loss 4.0%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (20% confidence) — position size reduced 4%
Signal Summary BUY
2
Bullish Signals
2
Bearish Signals
48.08
RSI(14)
1.4073
MACD
Relative Strength (RS) WEAK RS
24
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | → FLAT (-5.8% vs SPY 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | No (4d since high) |
| Sector Outperformance | +1.9% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
WEAK RS:
Underperformer — the stock is lagging the market. Avoid until RS trend reverses upward.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 48.08 | NEUTRAL |
| Macd | 1.4073 | BULLISH |
| Ma Cross | 53.31 / 55.49 | DEATH CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | BELOW SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.2x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 78.48 |
| Bollinger Upper | 61.61 |
| SMA(200) | 55.49 |
| SMA(50) | 53.31 |
| SMA(20) | 55.09 |
| Current Price | 53.46 |
| Bollinger Lower | 48.57 |
| 52-Week Low | 44.12 |
| ATR(14) | 3.37 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
ACCUMULATION E
Confidence
50%
Acc: 1.0 |
Dist: 1.0 |
Markup: 0.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-07-06 | Normal | 1.25x | Normal bar — no special VSA pattern |
| 2026-07-07 | Normal | 1.02x | Normal bar — no special VSA pattern |
| 2026-07-08 | Normal | 0.75x | Normal bar — no special VSA pattern |
| 2026-07-09 | Normal | 0.87x | Normal bar — no special VSA pattern |
| 2026-07-10 | Normal | 0.2x | Normal bar — no special VSA pattern |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 58.30 | Above Kijun |
| Kijun-sen (26) | 56.23 | Base line |
| Senkou A | 57.27 | Leading span A |
| Senkou B | 55.19 | Leading span B |
| Cloud | 55.19 – 57.27 | Bullish (Green) |
| Price vs Cloud | 54.39 | Below Cloud |
| Chikou Span | 52.08 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE OFF
No squeeze
Momentum:
BEARISH
BB: 48.57 – 61.61 | KC: 50.3 – 59.88
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bearish | RSI | 25 |
Anchored VWAP
VWAP: 53.29
Anchor: 2026-03-30 (52w Low)
ABOVE AVWAP
+2.1%
Heikin-Ashi Trend
BEARISH
Full data via /api/advanced/CRSP
Valuation
| Metric | Value |
|---|---|
| Market Cap | 5.26B |
| P/E (TTM) | N/A |
| Forward P/E | N/A |
| P/B | 2.84 |
| EPS | -6.17 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 68.6% |
| Profit Margin | N/A |
| ROE | -31.2% |
| Debt/Equity | 43.41 |
| Current Ratio | 17.96 |
| Dividend Yield | N/A |
| Payout Ratio | N/A |
| Beta | 1.70 |
Trading Data
53.46
Open
53.46
Day High
53.46
Day Low
250.7K
Volume (0.1x avg)
Recent News (8)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)